Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Jan 3, 2025 | 13.08 | +1.83 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Jan 3, 2025 | 3.59 | +1.70 |
NeueHealth | NEUE | Jan 3, 2025 | 7.31 | -0.27 |
Neumora Therapeutics | NMRA | Jan 3, 2025 | 2.17 | +10.15 |
Neuphoria Therapeutics | NEUP | Jan 3, 2025 | 3.40 | 0.00 |
Neuraxis | NRXS | Jan 3, 2025 | 2.42 | +2.98 |
Neurobo Pharmaceuticals | NRBO | Jan 3, 2025 | 2.36 | 0.00 |
Neurocrine Biosciences | NBIX | Jan 3, 2025 | 138.10 | +0.17 |
Neurogene | NGNE | Jan 3, 2025 | 23.23 | +1.49 |
NeuroMetrix | NURO | Jan 3, 2025 | 3.93 | -0.10 |
Neuronetics | STIM | Jan 3, 2025 | 1.49 | 0.00 |
NeuroOne | NMTC | Jan 3, 2025 | 0.92 | +11.54 |
Neuropace | NPCE | Jan 3, 2025 | 11.57 | -0.09 |
NeuroSense Therapeutics | NRSN | Jan 3, 2025 | 1.19 | +3.48 |
Nevro | NVRO | Jan 3, 2025 | 3.71 | 0.00 |
New America High Income Fund | HYB | Jan 3, 2025 | 8.21 | -0.18 |
New Century Logistics (BVI) Limited - Ordinary Shares | NCEW | Jan 3, 2025 | 2.27 | 0.00 |
New Concept Energy | GBR | Jan 3, 2025 | 1.16 | -1.78 |
New England Realty Associates LP Unit A | NEN | Jan 3, 2025 | 82.70 | 0.00 |
New Era Helium | NEHC | Jan 3, 2025 | 4.20 | 0.00 |
New Fortress Energy A | NFE | Jan 3, 2025 | 15.90 | -2.45 |
New Found Gold | NFGC | Jan 3, 2025 | 1.87 | -3.11 |
New Germany Fund | GF | Jan 3, 2025 | 7.85 | +1.03 |
New Gold | NGD | Jan 3, 2025 | 2.59 | -1.15 |
New Horizon Aircraft | HOVR | Jan 3, 2025 | 1.15 | +5.50 |
New Mountain Finance Corp | NMFC | Jan 3, 2025 | 11.33 | -0.09 |
New Oriental Education & Technology Group ADR | EDU | Jan 3, 2025 | 62.63 | +1.74 |
New Pacific Metals | NEWP | Jan 3, 2025 | 1.29 | +2.38 |
New Providence Acquisition II A | NPAB | Jan 3, 2025 | 11.30 | 0.00 |
New Providence Acquisition II Unit | NPABU | Jan 3, 2025 | 12.20 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.